ProMIS Neurosciences (PMN) said Monday that the US Food and Drug Administration granted Fast Track designation to its lead candidate PMN310 for treating Alzheimer's disease.
Shares more than doubled as intraday trading volume catapulted to over 268.2 million from a daily average of roughly 1.7 million.
ZimVie (ZIMV) said it agreed to be acquired and taken private by healthcare-focused investment firm Archimed for about $730 million.
Shares of ZimVie surged 122% as intraday trading volume climbed to more than 8.9 million from a daily average of about 146,000.
The Ether Machine (ETHM) announced Monday its public launch through a business combination between The Ether Reserve and Dynamix (DYNX).
Shares of Dynamix advanced nearly 16% as intraday trading volume soared to more than 22.2 million from a daily average of about 22,000.
Price: 1.10, Change: +0.66, Percent Change: +149.94
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.